The Huntington's Disease Collaborative Research Group: Cell. 1993, 72: 971-983. 10.1016/0092-8674(93)90585-E.
Article
Google Scholar
DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Yound C, Martin E, Vonsattel JP, Carraway R, Reeves SA, Boyce FM, Aronin N: Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 1995, 14: 1075-1081. 10.1016/0896-6273(95)90346-1.
Article
CAS
PubMed
Google Scholar
Kehoe P, Krawczak M, Harper PS, Owen MJ, Jones AL: Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet. 1999, 36: 108-111.
CAS
PubMed
PubMed Central
Google Scholar
Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature. 2000, 6810: 307-310. 10.1038/35042675.
Article
Google Scholar
Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM: The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A. 2000, 97: 6763-6768. 10.1073/pnas.100110097.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999, 19: 1092-1100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bonafe M, Salvioli S, Barbi C, Trapassi C, Tocco F, Storci G, Invidia L, Vannini I, Rossi M, Marzi E, Mishto M, Capri M, Olivieri F, Antonicelli R, Memo M, Uberti D, Nacmias B, Sorbi S, Monti D, Franceschi C: The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ. 2004, 11: 962-973. 10.1038/sj.cdd.4401415.
Article
CAS
PubMed
Google Scholar
Chattopadhyay B, Baksi K, Mukhopadhyay S, Bhattacharyya NP: Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes. Neurosci Lett. 2005, 374: 81-6. 10.1016/j.neulet.2004.10.018.
Article
CAS
PubMed
Google Scholar
Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998, 6662: 43-50.
Google Scholar
Arning L, Kraus PH, Valentin S, Saft C, Epplen JT: NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics. 2005, 6: 25-8. 10.1007/s10048-004-0198-8.
Article
CAS
PubMed
Google Scholar
Warner JP, Barron LH, Brock DJ: A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes. 1993, 7: 235-239. 10.1006/mcpr.1993.1034.
Article
CAS
PubMed
Google Scholar
Donehower LA: p53: guardian AND suppressor of longevity?. Exp Gerontol. 2005, 40: 7-9. 10.1016/j.exger.2004.10.007.
Article
CAS
PubMed
Google Scholar